Sort
141,003 grants matching “cytokine”
EPSTEIN BARR VIRUS LMP1 MEDIATED ONCOGENICITY
$705,115Brigham And Women'S Hospital · R01 · FY2003 · CA
A new model of regenerative healing via inflammation-modulating biomaterials
$705,109Ellen S. Heber-Katz · Lankenau Institute For Medical Research · R01 · FY2021 · DE
A new model of regenerative healing via inflammation-modulating biomaterials
$705,109Ellen S. Heber-Katz · Lankenau Institute For Medical Research · R01 · FY2019 · DE
A new model of regenerative healing via inflammation-modulating biomaterials
$705,109Ellen S. Heber-Katz · Lankenau Institute For Medical Research · R01 · FY2018 · DE
A new model of regenerative healing via inflammation-modulating biomaterials
$705,109Ellen S. Heber-Katz · Lankenau Institute For Medical Research · R01 · FY2020 · DE
Chromosome movements that regulate tissue-specific gene expression
$705,102Ranjan Sen · National Institute On Aging · ZIA · FY2023 · AG
The Gut Microbiome Brain Axis and Preterm Infants
$705,079Erika C Claud · University Of Chicago · R01 · FY2021 · HD
Chronic Wasting Disease Vaccines
$705,042Candace K. Mathiason · Colorado State University · R01 · FY2025 · AI
Dopaminergic Therapy for Inflammation-Related Anhedonia in Depression
$705,020Jennifer C Felger · Emory University · R33 · FY2023 · MH
Long-term Effects of IDU, HIV, HCV and the Impact of HCV Cure on Immune Activation and Liver Fibrosis in Aging Women
$705,013Andrea A. Kovacs · University Of Southern California · R01 · FY2018 · DA
PERSISTENCE OF PROTECTION CONFERRED BY SHINGRIX AGAINST HERPES ZOSTER IN OLDER ADULTS
$704,995Adriana Weinberg · University Of Colorado Denver · U01 · FY2021 · AI
Novel Molecular Target to Prevent Maturation Failure of Arteriovenous Fistula
$704,979Devendra K. Agrawal · Western University Of Health Sciences · R01 · FY2020 · HL
Novel Molecular Target to Prevent Maturation Failure of Arteriovenous Fistula
$704,979Devendra K. Agrawal · Western University Of Health Sciences · R01 · FY2022 · HL
Novel Molecular Target to Prevent Maturation Failure of Arteriovenous Fistula
$704,979Devendra K. Agrawal · Western University Of Health Sciences · R01 · FY2021 · HL
Novel Molecular Target to Prevent Maturation Failure of Arteriovenous Fistula
$704,979Devendra K. Agrawal · Western University Of Health Sciences · R01 · FY2019 · HL
Nanoparticle-mediated reprogramming of circulating monocytes and neutrophils to decrease inflammation-mediated damage after trauma
$704,971Lonnie D Shea · University Of Michigan At Ann Arbor · R01 · FY2019 · AI
Development of safe and efficient gene therapy strategies for hemoglobinopathies
$704,921Hans-Peter Kiem · Fred Hutchinson Cancer Research Center · R01 · FY2011 · HL
Examining IL-15 as an immunotherapy agent in cancer and AIDS
$704,873Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
COVID-19 vaccine in naive individuals and cancer patients
$704,873Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Pathogenesis of Dyslipidemia and Atherosclerosis in the Diabetic State
$704,867Sudha B Biddinger · Boston Children'S Hospital · R01 · FY2023 · HL
Inflammatory Genomics in Human Carotid Artery Disease
$704,850University Of Washington · R01 · FY2004 · HL
Mechanisms associated with flares and remission in colitis
$704,833Sergio A Lira · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · DK
Very early drivers of neutrophilic inflammation in cardiac ischemia-reperfusion
$704,821Rebecca Diane Levit · Emory University · R01 · FY2024 · HL
Very early drivers of neutrophilic inflammation in cardiac ischemia-reperfusion
$704,821Rebecca Diane Levit · Emory University · R01 · FY2025 · HL
In-vivo imaging of spinal and brain glial activation in low back pain patients
$704,809Marco Luciano Loggia · Massachusetts General Hospital · R01 · FY2016 · NS